U.S. Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By End-use (Medical Use, Recreational Use), By Cultivation (Indoor, Outdoor), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 4 Business Days
U.S. Cannabis Market Growth & Trends
The U.S. cannabis market size is anticipated t%li%reach USD 76.39 billion by 2030 and is projected t%li%grow at a CAGR of 12.10% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected t%li%boost the market growth.
Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected t%li%be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according t%li%an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated t%li%occur in the U.S. In addition t%li%that, tw%li%cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.
Rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.
With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking t%li%benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity’s involvement in the cultivation process. Despite this scrutiny, more celebrities are expected t%li%follow this trend and enter the cannabis cultivation industry.
New technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated t%li%assist cultivators in optimizing their resources, which further drives the market growth.
U.S. Cannabis Market Report Highlights
U.S. Cannabis Market Growth & Trends
The U.S. cannabis market size is anticipated t%li%reach USD 76.39 billion by 2030 and is projected t%li%grow at a CAGR of 12.10% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected t%li%boost the market growth.
Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected t%li%be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according t%li%an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated t%li%occur in the U.S. In addition t%li%that, tw%li%cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.
Rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.
With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking t%li%benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity’s involvement in the cultivation process. Despite this scrutiny, more celebrities are expected t%li%follow this trend and enter the cannabis cultivation industry.
New technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated t%li%assist cultivators in optimizing their resources, which further drives the market growth.
U.S. Cannabis Market Report Highlights
- Based on source, the marijuana segment led the market with the largest revenue share of 86.91% in 2023, due t%li%the recognition of cannabis for medical purposes and the increasing legalization of its use
- Based on derivative, the CBD segment led the market with the largest revenue share of 64.7% in 2023, owing t%li%growing acceptance and a rise in demand for CBD-infused food, cosmetics, and medication
- Based on cultivation, the indoor cultivation segment led the market with the largest revenue share of 54.59% in 2023, owing t%li%favorable government initiatives and investment made by key players in the market
- Based on end use, the medical use segment led the market with the largest revenue share of 66.41% in 2023 due t%li%the increasing research activity and growing clinical trials supporting its benefits in treating various chronic disease.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source
1.2.2. Derivatives
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End Use outlook
2.3. Competitive Landscape Snapshot
CHAPTER 3. U.S. CANNABIS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
3.2.1.2. Impending legalization of marijuana for recreational/adult use
3.2.1.3. Rising number of research studies on cannabis for various ailments
3.2.1.4. Growing legalization and awareness of cannabis in various states in the U.S.
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of cannabis and CBD-based products
3.2.2.2. lack of consistency in advertising policies regarding cannabis
3.2.3. Case Study Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.4. Regulatory Landscape
CHAPTER 4. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)
4.1. Definition and Scope
4.2. Source Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Hemp
4.4.1. Hemp Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Hemp oil
4.4.2.1. Hemp Oil Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Industrial Hemp
4.4.3.1. Industrial Hemp Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Marijuana
4.5.1.1. Marijuana Market estimates and forecasts, 2018 to 2030, (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY DERIVATIVE, 2018 - 2030 (USD MILLION)
5.1. Definition and Scope
5.2. Derivatives Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. CBD
5.4.1. CBD Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. THC
5.5.1. THC Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY CULTIVATION, 2018 - 2030 (USD MILLION)
6.1. Definition and Scope
6.2. Cultivation Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Indoor Cultivation
6.4.1. Indoor Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Greenhouse Cultivation
6.5.1. Greenhouse Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Outdoor Cultivation
6.6.1. Outdoor Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION)
7.1. Definition and Scope
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4. Industrial
7.4.1. Industrial Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Medical
7.5.1. Medical Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. Chronic Pain
7.5.2.1. Chronic Pain Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Depression and Anxiety
7.5.3.1. Depression and Anxiety Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Arthritis
7.5.4.1. Arthritis Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Post Traumatic Stress Disorder (PTSD)
7.5.5.1. Post Traumatic Stress Disorder (PTSD) Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Cancer
7.5.6.1. Cancer Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Migraines
7.5.7.1. Migraines Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Epilepsy
7.5.8.1. Epilepsy Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Alzheimer’s Disease
7.5.9.1. Alzheimer’s Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Multiple Sclerosis Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.11. Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis
7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.12. Tourette’s Syndrome
7.5.12.1. Tourette’s Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.13. Diabetes
7.5.13.1. Diabetes Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.14. Parkinson's Disease
7.5.14.1. Parkinson's Disease Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.15. Glaucoma
7.5.15.1. Glaucoma Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.16. AIDS
7.5.16.1. AIDS Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.17. Others
7.5.17.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Recreational
7.6.1. Recreational Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company Categorization
8.3. Company Market Position Analysis
8.4. Company Profiles
8.4.1. Tilray Brands
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Service Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Canopy Growth Corporation
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Service Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Medical Marijuana, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Service Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. NuLeaf Naturals, LLC
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Service Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. CV Sciences, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Service Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. CHARLOTTE’S WEB.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Service Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. The Cronos Group
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Service Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Organigram Holding, Inc
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Service Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Irwin Naturals
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Service Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Aurora Cannabis
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Service Benchmarking
8.4.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source
1.2.2. Derivatives
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End Use outlook
2.3. Competitive Landscape Snapshot
CHAPTER 3. U.S. CANNABIS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
3.2.1.2. Impending legalization of marijuana for recreational/adult use
3.2.1.3. Rising number of research studies on cannabis for various ailments
3.2.1.4. Growing legalization and awareness of cannabis in various states in the U.S.
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of cannabis and CBD-based products
3.2.2.2. lack of consistency in advertising policies regarding cannabis
3.2.3. Case Study Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.4. Regulatory Landscape
CHAPTER 4. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)
4.1. Definition and Scope
4.2. Source Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Hemp
4.4.1. Hemp Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Hemp oil
4.4.2.1. Hemp Oil Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Industrial Hemp
4.4.3.1. Industrial Hemp Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Marijuana
4.5.1.1. Marijuana Market estimates and forecasts, 2018 to 2030, (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY DERIVATIVE, 2018 - 2030 (USD MILLION)
5.1. Definition and Scope
5.2. Derivatives Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. CBD
5.4.1. CBD Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. THC
5.5.1. THC Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY CULTIVATION, 2018 - 2030 (USD MILLION)
6.1. Definition and Scope
6.2. Cultivation Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Indoor Cultivation
6.4.1. Indoor Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Greenhouse Cultivation
6.5.1. Greenhouse Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Outdoor Cultivation
6.6.1. Outdoor Cultivation Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. U.S. CANNABIS MARKET SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION)
7.1. Definition and Scope
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4. Industrial
7.4.1. Industrial Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Medical
7.5.1. Medical Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. Chronic Pain
7.5.2.1. Chronic Pain Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Depression and Anxiety
7.5.3.1. Depression and Anxiety Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Arthritis
7.5.4.1. Arthritis Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Post Traumatic Stress Disorder (PTSD)
7.5.5.1. Post Traumatic Stress Disorder (PTSD) Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Cancer
7.5.6.1. Cancer Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Migraines
7.5.7.1. Migraines Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Epilepsy
7.5.8.1. Epilepsy Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Alzheimer’s Disease
7.5.9.1. Alzheimer’s Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Multiple Sclerosis Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.11. Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis
7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.12. Tourette’s Syndrome
7.5.12.1. Tourette’s Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.13. Diabetes
7.5.13.1. Diabetes Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.14. Parkinson's Disease
7.5.14.1. Parkinson's Disease Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.15. Glaucoma
7.5.15.1. Glaucoma Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.16. AIDS
7.5.16.1. AIDS Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.17. Others
7.5.17.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Recreational
7.6.1. Recreational Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company Categorization
8.3. Company Market Position Analysis
8.4. Company Profiles
8.4.1. Tilray Brands
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Service Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Canopy Growth Corporation
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Service Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Medical Marijuana, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Service Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. NuLeaf Naturals, LLC
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Service Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. CV Sciences, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Service Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. CHARLOTTE’S WEB.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Service Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. The Cronos Group
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Service Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Organigram Holding, Inc
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Service Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Irwin Naturals
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Service Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Aurora Cannabis
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Service Benchmarking
8.4.10.4. Strategic Initiatives
LIST OF TABLES
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. cannabis market, by source, 2018 - 2030 (USD Million)
Table 4. U.S. cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5. U.S. cannabis market, by End Use, 2018 - 2030 (USD Million)
Table 6. U.S. cannabis market, by cultivation, 2018 - 2030 (USD Million)
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. cannabis market, by source, 2018 - 2030 (USD Million)
Table 4. U.S. cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5. U.S. cannabis market, by End Use, 2018 - 2030 (USD Million)
Table 6. U.S. cannabis market, by cultivation, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Primary Research Process
Fig. 4 Market Research Approaches - Bottom-Up Approach
Fig. 5 Market Research Approaches - Top-Down Approach
Fig. 6 Market Research Approaches - Combined Approach
Fig. 7 Wellhead Components Market- Market Snapshot
Fig. 8 Wellhead Components Market- Segment Snapshot (1/2)
Fig. 9 Wellhead Components Market- Segment Snapshot (2/2)
Fig. 10 Wellhead Components Market- Competitive Landscape Snapshot
Fig. 11 Wellhead Components Market: Penetration & Growth Prospect Mapping
Fig. 12 Wellhead Components Market: Value Chain Analysis
Fig. 13 Wellhead Components Market: Porter’s Five Force Analysis
Fig. 14 Wellhead Components Market: PESTEL Analysis
Fig. 15 Wellhead Components market: Product Movement Analysis, 2023 & 2030
Fig. 16 Wellhead Components market: Application Movement Analysis, 2023 & 2030
Fig. 17 Wellhead Components market: Regional Movement Analysis, 2023 & 2030
Fig. 18 Wellhead Components Market: Competitive Dashboard Analysis
Fig. 19 Wellhead Components Market: Market Share Analysis
Fig. 20 Wellhead Components Market: Market Positioning Analysis
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Primary Research Process
Fig. 4 Market Research Approaches - Bottom-Up Approach
Fig. 5 Market Research Approaches - Top-Down Approach
Fig. 6 Market Research Approaches - Combined Approach
Fig. 7 Wellhead Components Market- Market Snapshot
Fig. 8 Wellhead Components Market- Segment Snapshot (1/2)
Fig. 9 Wellhead Components Market- Segment Snapshot (2/2)
Fig. 10 Wellhead Components Market- Competitive Landscape Snapshot
Fig. 11 Wellhead Components Market: Penetration & Growth Prospect Mapping
Fig. 12 Wellhead Components Market: Value Chain Analysis
Fig. 13 Wellhead Components Market: Porter’s Five Force Analysis
Fig. 14 Wellhead Components Market: PESTEL Analysis
Fig. 15 Wellhead Components market: Product Movement Analysis, 2023 & 2030
Fig. 16 Wellhead Components market: Application Movement Analysis, 2023 & 2030
Fig. 17 Wellhead Components market: Regional Movement Analysis, 2023 & 2030
Fig. 18 Wellhead Components Market: Competitive Dashboard Analysis
Fig. 19 Wellhead Components Market: Market Share Analysis
Fig. 20 Wellhead Components Market: Market Positioning Analysis
